M&As this week: Ardena Group, Sumitomo Chemical - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

M&As this week: Ardena Group, Sumitomo Chemical

29 Sep 2017

Belgian contract development and manufacturing organisation Ardena Group has completed the acquisition of Netherlands-based bioanalytical contract laboratory services provider Analytical Biochemical Laboratory.

Belgian contract development and manufacturing organisation Ardena Group has completed the acquisition of Netherlands-based bioanalytical contract laboratory services provider Analytical Biochemical Laboratory.

The acquisition enables Ardena to expand its pre-clinical and clinical offerings.

Sumitomo Chemical plans to acquire 20% stake in nucleic acid medicines developer Bonac for CNY4bn ($35.64m).

“Sumitomo Chemical plans to acquire 20% stake in nucleic acid medicines developer Bonac for CNY4bn ($35.64m).”

The acquisition will enable Bonac to expand its new drug development and manufacturing business.

Both the acquirer and target companies are based in Japan.